Macroscopic and microscopic morphology on selective media distinguishes yeasts and molds in the clinical mycology lab
Clinical mycology begins with proper specimen collection and inoculation onto media formulated to favor fungal recovery while suppressing the far faster-growing bacterial flora that would otherwise overgrow a plate within hours. The choice of media and supplements is itself a diagnostic decision, shaped by the suspected organism and specimen source.
Fungal pathogens are recovered from a wide range of specimen types, each with specific handling requirements:
• Blood: inoculated into fungal-specific or lysis-centrifugation blood culture bottles; standard aerobic bottles detect Candida reasonably well but miss many molds and Cryptococcus • Skin scrapings/nail clippings: collected from the leading edge of a lesion after alcohol disinfection; examined by direct KOH mount before culture • Respiratory specimens (sputum, BAL): processed promptly as environmental mold contamination is common; BAL preferred for invasive aspergillosis • CSF: centrifuged (cytospin) to concentrate low fungal burden; critical specimen for Cryptococcus meningitis, where organism burden may be very low despite severe disease • Tissue biopsy: minced/ground before plating; also submitted for histopathology (GMS, PAS stains) in parallel
Specimens should reach the laboratory within 2 hours at room temperature; refrigeration is preferred for specimens with anticipated bacterial contamination (skin, respiratory) but can reduce recovery of some fastidious molds.
No single medium recovers every clinically relevant fungus optimally, so the mycology bench routinely inoculates a primary panel:
• Sabouraud dextrose agar (SDA): the historical workhorse — high dextrose concentration (4%) and acidic pH (5.6) favor fungal over bacterial growth; supports growth of virtually all clinically significant yeasts and molds • Inhibitory mold agar (IMA) / Brain-heart infusion (BHI) with antibiotics: enriched formulations improve recovery of fastidious or slow-growing molds and dimorphic fungi • Birdseed (niger seed) agar: selective and differential for Cryptococcus neoformans/gattii — the organism's phenol oxidase converts a substrate in the seed extract into melanin, turning colonies brown/black within 48–72 hours; most other yeasts remain unpigmented • CHROMagar Candida: chromogenic medium producing species-characteristic colony colors (green for C. albicans, blue-gray for C. tropicalis, pink for C. krusei) — useful for rapid presumptive speciation and detecting mixed yeast infections • Antibacterial supplementation: chloramphenicol and/or gentamicin added routinely; cycloheximide historically added to suppress rapid saprophytic mold contaminants but is avoided when Cryptococcus or certain dimorphic fungi are suspected, since it also inhibits their growth
Cycloheximide-containing media (e.g., Mycosel) will suppress Cryptococcus neoformans, Aspergillus, and the Mucorales — so a parallel cycloheximide-free plate must always be inoculated whenever these organisms are clinical possibilities.
Plates are incubated at 25–30°C (favoring mold sporulation and dimorphic fungi in the mold phase) and often in parallel at 35–37°C (favoring yeast growth and the dimorphic fungi's tissue/yeast phase), for a minimum of 2–4 weeks before a culture is called negative — far longer than routine bacterial cultures held only 24–48 hours.
Biosafety is a central concern: suspected mold cultures, particularly from respiratory sources in endemic areas, should be handled in a biological safety cabinet given the risk of aerosolizing infectious conidia (notably Coccidioides, Histoplasma, and Blastomyces, which are BSL-3 handling risks in their mold phase). Plates are taped shut rather than opened on the open bench once heavy mold growth is observed.
Macroscopic colony characteristics are the first and often most rapidly available diagnostic clue in the mycology laboratory. Growth rate alone narrows the differential dramatically: a colony visible within 24–48 hours is almost never a slow-growing mold, while an organism still sporulating after two weeks is unlikely to be a yeast.
Fungal colony growth rate is conventionally described relative to a standard incubation period, and it is one of the fastest, cheapest pieces of diagnostic information a laboratory generates:
• Yeasts (Candida, Cryptococcus): smooth, moist to mucoid colonies typically visible within 24–72 hours; mature morphology by day 3–4 • Rapid molds (Mucorales — Mucor, Rhizopus, Rhizomucor): notoriously the fastest-growing clinically significant molds, capable of filling an entire 90–100mm plate with fluffy aerial mycelium within 24–48 hours — so fast and tall-growing they are colloquially called "lid lifters" in the lab • Intermediate molds (Aspergillus spp.): visible growth by day 2–3, but full colony color and sporulation characteristic of the species typically requires 5–7 days • Slow/dimorphic molds (Histoplasma, Blastomyces, Coccidioides): may take 1–4 weeks to produce identifiable colonies, requiring prolonged incubation before a culture can be reported negative
A mold that overruns a Sabouraud plate within 48 hours with tall, cottony gray-white aerial growth lacking visible pigment should immediately raise suspicion for a Mucorales agent — a critical alert given the aggressive, angioinvasive nature of mucormycosis.
Beyond growth rate, texture and pigmentation refine the differential substantially:
• Texture descriptors: waxy/pasty (most yeasts), cottony/floccose (Mucorales, many dermatophytes), velvety/granular (Aspergillus, Penicillium), powdery (heavily sporulating conidial molds) • Surface topography: flat vs. heaped/umbonate (raised center) vs. folded/cerebriform • Obverse (surface) color: often organism-characteristic — Aspergillus fumigatus is blue-green to gray-green with a white apical margin; Aspergillus niger produces a strikingly jet-black, granular surface; Aspergillus flavus is yellow-green • Reverse (underside, viewed through the agar) color and diffusible pigment: examined by flipping the plate — some species (notably certain dermatophytes and Aspergillus spp.) diffuse pigment into the agar itself, a feature invisible from the colony surface alone • Cryptococcus on standard SDA: smooth, mucoid, cream to tan colonies reflecting the thick polysaccharide capsule; on birdseed agar, melanin production turns colonies brown to black over 48–96 hours, a feature specific to the Cryptococcus neoformans/gattii species complex among clinically encountered yeasts
Mycology benches typically examine plates on a defined schedule (e.g., day 1, 2, 3, 5, 7, 14, and weekly thereafter), photographing and documenting colony diameter, color change, and texture evolution at each check. Because morphology can shift substantially over the culture period — a young Aspergillus colony may appear white and featureless for the first 48 hours before developing its characteristic pigmented conidial layer — premature morphologic calls are a recognized source of misidentification, and final identification is deferred until sporulation is mature enough for confident assessment.
While colony morphology narrows the differential, definitive fungal identification rests on microscopic architecture. A slide culture (Riddell technique) or clear cellulose tape preparation stained with lactophenol cotton blue (LPCB) preserves the delicate three-dimensional relationship between hyphae, conidiophores, and spores — the single most information-dense diagnostic step in mycology.
Candida species are identified microscopically by their yeast-form growth pattern:
• Blastoconidia (budding yeast cells): oval, 3–7 µm cells reproducing by narrow-based budding, visible in wet mounts or on cornmeal-Tween 80 agar • Pseudohyphae: elongated budding cells that fail to separate, forming chains with constrictions at the septal junctions — resembling a string of sausages — distinguishing them from true hyphae, which have parallel, non-constricted walls • True hyphae: Candida albicans uniquely produces true septate hyphae in addition to pseudohyphae and blastoconidia under appropriate conditions, a feature exploited diagnostically • Chlamydospores: thick-walled, refractile terminal spores produced by C. albicans on cornmeal agar under reduced oxygen/nutrient stress — a classic confirmatory microscopic feature
Cryptococcus neoformans appears as spherical to oval budding yeast cells, 4–10 µm, distinguished from Candida by a wide, often narrow-based single bud and — critically — a thick polysaccharide capsule visible as a clear halo surrounding the cell body on India ink preparation.
The presence or absence of hyphal septation is a first-order microscopic branch point separating two major mold groups with very different clinical implications:
Septate hyphae (Aspergillus, Fusarium, dematiaceous molds): • Regular cross-walls (septa) divide the hyphal tube into discrete cellular compartments • Hyphae are uniform in width (3–6 µm) with walls running roughly parallel • Branching typically at acute (~45°) angles for Aspergillus • Conidiophores arise from specialized "foot cells" and terminate in a swollen vesicle bearing phialides that produce long chains of conidia (spores) — the classic "aspergillus head"
Non-septate (pauci-septate) ribbon hyphae (Mucorales — Mucor, Rhizopus, Rhizomucor, Lichtheimia): • Broad (6–25 µm), irregular, ribbon-like hyphae with few or no septa • Branching at wide, often right (~90°) angles • Lack of septa allows cytoplasmic organelles to stream freely through the hyphal tube — a structural fragility that also makes these hyphae prone to folding and twisting artifacts on slide prep • Sporangiophores terminate in a swollen sporangium containing hundreds of sporangiospores, released upon rupture of the sporangial wall — mechanistically distinct from the chain-forming conidiogenesis of Aspergillus • Rhizopus is distinguished from Mucor by the presence of rhizoids (root-like hyphae) at the point where the sporangiophore arises
Non-septate ribbon hyphae seen on a KOH mount or frozen section from a diabetic ketoacidosis patient with sino-orbital symptoms is a surgical and infectious disease emergency — angioinvasive mucormycosis can progress from diagnosis to death within days without aggressive surgical debridement and amphotericin B.
The Riddell slide culture technique inoculates a small block of agar placed on a microscope slide, covered with a coverslip, and incubated in a moist chamber for several days. Because the fungus grows directly against the coverslip and slide, delicate three-dimensional conidiophore architecture — which is easily destroyed by teasing colonies apart with an inoculating needle — is preserved intact for LPCB-stained examination.
This is essential for mold identification, where the arrangement of conidiophores, phialides, and conidial chains (not merely their presence) determines the genus and species call: Aspergillus, Penicillium, and the dermatophytes are distinguished largely by conidiophore branching pattern and conidial arrangement rather than hyphal width alone.
Colony and hyphal morphology narrow the diagnosis to a genus or small group of look-alike species, but several rapid, inexpensive confirmatory tests resolve the identification to species level — often faster and more definitively than waiting for full sporulation or sending isolates for molecular sequencing.
The germ tube test remains one of the most useful rapid tests in clinical mycology despite its simplicity: a yeast colony suspension is incubated in a small volume of animal serum (or serum substitute) at 35–37°C for 2–3 hours. Candida albicans (and the closely related C. dubliniensis) produce germ tubes — slender hyphal extensions from the yeast cell without a constriction at the point of origin, distinguishing a true germ tube from an early pseudohypha which does show a constriction.
A positive germ tube test in the setting of typical colony morphology is considered presumptively diagnostic for C. albicans, allowing same-day reporting rather than waiting for slower biochemical or chromogenic confirmation. Nearly all other Candida species (C. glabrata, C. krusei, C. tropicalis, C. parapsilosis) are germ tube negative, so a negative result shifts the differential toward these species, each with distinct antifungal susceptibility profiles clinically relevant to therapy selection.
Two complementary rapid tests confirm Cryptococcus neoformans/gattii:
• Urease test: Cryptococcus, like other basidiomycetous yeasts, produces urease that hydrolyzes urea to ammonia, shifting a phenol red indicator medium to pink within hours (often <4h for heavy inocula) — useful to rapidly distinguish Cryptococcus from urease-negative yeasts such as Candida, though it does not distinguish Cryptococcus from a few other urease-positive yeast genera (e.g., Trichosporon), so it is used alongside morphology rather than in isolation
• India ink preparation: a drop of India ink mixed with CSF or a yeast suspension is examined under light microscopy; the polysaccharide capsule excludes the ink particles, producing a clear halo around the yeast cell body against the dark background — classically described as a "halo sign." Sensitivity in CSF is only moderate (roughly 50–80%, lower with low fungal burden), so a negative India ink does not exclude cryptococcal meningitis, and cryptococcal antigen (CrAg) testing (latex agglutination or lateral flow assay) has largely supplanted India ink as the front-line rapid diagnostic given its substantially higher sensitivity (~95–100%) and specificity
The cryptococcal capsule is a major virulence factor: it is anti-phagocytic, sheds soluble polysaccharide (glucuronoxylomannan) that suppresses host immune responses, and its thickness can expand dramatically in vivo relative to in vitro culture — capsule diameter up to 30 µm has been documented in tissue, versus a thin or absent capsule on standard laboratory media.
For filamentous molds, a small tease or slide-culture preparation mounted in lactophenol cotton blue (LPCB) stain is examined for the definitive genus/species-determining architecture:
• Phenol component: kills and fixes the fungal elements, halting further growth and preventing operator infection risk from viable spores • Lactic acid: preserves fungal structures and prevents desiccation/distortion • Cotton blue (aniline blue) dye: stains chitin in the fungal cell wall, providing contrast for visualizing hyphae, conidiophores, and spore arrangement
Key features assessed: conidiophore length and pigmentation, vesicle shape (globose vs. clavate, relevant for distinguishing Aspergillus species), uniseriate vs. biseriate phialide arrangement, conidial chain length and color, and — for the Mucorales — sporangiophore branching pattern and the presence/absence of rhizoids and apophyses. This single stained mount, examined by an experienced mycology technologist, is frequently sufficient for confident genus- and often species-level identification without need for molecular sequencing.
A laboratory identification only becomes clinically actionable once it is interpreted in the context of the patient: is this isolate representing true invasive infection, or colonization/contamination? Host immune status, specimen source, and quantity of growth all factor into this judgment, which in turn determines whether — and which — antifungal therapy is warranted.
Fungi, particularly Candida and Aspergillus, are frequently recovered from non-sterile sites (sputum, skin, urine, wounds) as colonizers or environmental contaminants without indicating disease requiring treatment. Interpretation hinges on:
• Specimen sterility: growth from blood, CSF, or a sterile-site biopsy is far more concerning than growth from sputum or a superficial wound swab • Quantity and repeatability: heavy, repeated growth of the same organism across multiple specimens strengthens the case for true infection over a single light, mixed-flora isolate • Host status: immunocompromised hosts (neutropenia, transplant, high-dose corticosteroids, uncontrolled diabetes/DKA) have dramatically lower thresholds for treating a positive culture, since colonization can rapidly progress to invasive disease in the absence of normal immune containment • Corroborating evidence: histopathology showing tissue invasion (hyphae or yeast within tissue, not just on a mucosal surface), radiographic findings (halo sign or air-crescent sign for invasive aspergillosis), and serologic/antigen markers (galactomannan for Aspergillus, beta-D-glucan, cryptococcal antigen) support a call of true invasive infection
Species-level identification directly determines antifungal choice because intrinsic susceptibility varies substantially across fungal genera and species:
• Candida albicans: generally fluconazole-susceptible; echinocandins (caspofungin, micafungin) preferred first-line for invasive candidemia pending susceptibility given rising azole resistance in some centers • Candida glabrata / C. krusei: reduced or intrinsic fluconazole resistance — echinocandin first-line; C. auris (an emerging multidrug-resistant species) may show resistance across azoles, echinocandins, and even amphotericin B, requiring susceptibility-guided therapy and strict infection control • Aspergillus fumigatus: voriconazole first-line for invasive aspergillosis; amphotericin B and isavuconazole as alternatives; azole-resistant strains are an emerging concern • Cryptococcus neoformans: induction therapy with liposomal amphotericin B plus flucytosine, followed by fluconazole consolidation/maintenance — a regimen fundamentally different from other yeast infections • Mucorales (Mucor, Rhizopus): intrinsically resistant to voriconazole — a critical distinguishing point, since empiric voriconazole (appropriate for suspected aspergillosis) will fail against mucormycosis; high-dose liposomal amphotericin B plus urgent surgical debridement is required
Because Mucorales are voriconazole-resistant while Aspergillus is voriconazole-susceptible, rapid and accurate microscopic distinction between septate (Aspergillus) and non-septate ribbon (Mucorales) hyphae directly changes empiric antifungal selection — a morphologic call with immediate, life-or-death therapeutic consequences.
Final mycology reports integrate organism identification, growth characteristics, and — when performed — antifungal susceptibility testing (broth microdilution per CLSI M27/M38 standards) into an actionable clinical report. Critical or unexpected results (Cryptococcus from CSF, non-septate hyphae from a diabetic ketoacidosis patient, a mold from a normally sterile site) are typically communicated directly to the ordering clinician by phone as a "critical value" rather than left for routine chart review, given the time-sensitive nature of antifungal decision-making in these scenarios. Coordination with infectious disease and, for angioinvasive mold infections, surgical teams is essential — antifungal therapy alone is frequently insufficient for mucormycosis without source-control debridement.
| Product | Indication | Trial Design | Key Result |
|---|---|---|---|
| Candida albicans | |||
| Aspergillus fumigatus | |||
| Cryptococcus neoformans | |||
| Mucor / Rhizopus spp. |